1 / 18

E-222 Working Group Meeting DEA CSOS Pilot Discussion

E-222 Working Group Meeting DEA CSOS Pilot Discussion. March 18, 2002. Agenda. Phase I: Status Phase I: Lessons Learned Phase II: Goals Phase II: Participant Requirements Phase III: Planning Ahead Questions…. Phase I: Status. 21 registered participants in Phase I

jackson-daugherty
Download Presentation

E-222 Working Group Meeting DEA CSOS Pilot Discussion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. E-222 Working Group Meeting DEA CSOS Pilot Discussion March 18, 2002

  2. Agenda • Phase I: Status • Phase I: Lessons Learned • Phase II: Goals • Phase II: Participant Requirements • Phase III: Planning Ahead • Questions…

  3. Phase I: Status • 21 registered participants in Phase I • 8 digital certificates have been issued • 6 completed test plans have been received (30% return rate to-date): • Mutual Drug • McKesson Corp. • McQueary Bros. Drug Company • Baxter Healthcare Corp. • Mallinckrodt Pharmaceuticals • Purdue Pharmacies LP

  4. Phase I: Lessons Learned • Manual easily retrieved and read – noting some recommended changes! • A couple of screen shots need to be updated in the manual. • No problems with certificate download times or errors. Total test time is averaging about 45 minutes. • Statistics will be compiled and made available once all test plans have been received. • So far so good!!!!

  5. Registration Time Breakdown

  6. Browser Compatibility

  7. Phase I Timeline

  8. Phase II: Goals • Test forms validation process • Select registered location/POA – begin thinking about who you will select • Download forms • Notarization • Validate submission and adjudication process

  9. Phase II Timeline

  10. Phase II: Participant Requirements • Tester must be affiliated with actual DEA registered location • Forms must be properly notarized

  11. Phase III: Planning Ahead • Identify those participants who are willing and able to commit the resources (time and infrastructure) • Transaction sets should be finalized • Workflows should be baselined

  12. Phase III Target Scope – Key Areas • Order signing • Order verification • Record retention (signed order, linked data, digital certificate)

  13. Phase III Part A) Signing • Order Signing • Identification of “to-be-signed” data • Activation of private key • Signature generation (supported algorithms) • Success Factors/Evaluation Criteria • Data format & technical compatibility—signing approach • Compatibility with current/planned workflow • Scalability (bulk orders, certificate management) • Performance • FIPS compliance

  14. Phase III Part B) – Verification • Order Verification/Processing • Parsing of digital certificate [address, schedules] • Certificate Revocation List (CRL) access/processing • Order validation [integrity check, CRL check, certificate expiry check, date of order] • Success Factors/Evaluation Criteria • Verification logic • Compatibility with current/planned workflow • Archival compliance • Connectivity- support for LDAP through org. firewall • Performance (Internet-based • FIPS compliance

  15. Phase III Part C) – Record Retention • Record Retention • Signed data [Order content] • Certificate data [Linked certificate or attached certificate?, address from certificate] • Linked data [distribution center(s), fill information, receipt information] • Success Factors/Evaluation Criteria • Readily retrievable • Integrity maintenance

  16. Phase III Logistics • How can the group divide and conquer? • … or, can Pilot participation be tailored to the partner’s business category (Pharmacy, Distributor, Manufacturer) • Order Signing—Pharmacies, Distributors • Order Verification —Distributors, manufacturers • Can simplifications be made that ease Pilot development without eliminating lessons learned? • Order generation (existing system vs. word processor) • Order transport (existing system vs. FTP Vs. email) • Will software need to be developed? • If so, how can the development be shared? • If so, can a single toolkit be used?

  17. Phase III Immediate Next Steps • Solidify Phase III Approach • Identify teams (signing, verifying) • Identify order format (EDI 850) • Identify signature approach (inside/outside) • Identify signing toolkit (EDI, Toolkit, other) • Estimate critical path milestones • ID estimated time to complete future workflows • ID estimated time to complete EDI 850 • Begin exploring tech areas ID skill requirements • Develop more detailed Phase III project plan

  18. Questions

More Related